Page last updated on September 26, 2024
Benitec Biopharma Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-09-26 16:30:45 EDT.
Filings
10-K filed on 2024-09-26
Benitec Biopharma Inc. filed a 10-K at 2024-09-26 16:30:45 EDT
Accession Number: 0001193125-24-226968
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Item 1C. Cybersecurity. Risk Management and Strategy We have implemented and maintain an information security program designed to identify, assess, and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data including intellectual property, clinical trial participant and patient-related data, and confidential information that is proprietary, strategic or competitive in nature. We believe our information security program is appropriate for a company of our size and stage of development, taking into account our operations and risks. Our cybersecurity policies and processes include: - Mechanisms, controls, and technologies designed to prevent or mitigate system intrusion or data loss, theft, misuse, or other security incidents or vulnerabilities and maintain a stable and secure information technology environment. - Information security policies, network and device security, encryption standards, risk management, as well as security tools such as malware protection and secure authentication tools. - We conduct ongoing monitoring of critical systems for any compromised or potentially compromised accounts, and conduct regular trainings for our employees and senior management on cyber and information security. Governance The Audit Committee of our Board of Directors oversees and reviews the Company’s cybersecurity risks and the steps management has taken to protect against threats to the Company’s information systems and security. The senior leadership team, including our Executive Director and Chief Executive Officer, provides periodic reports to our Board and the Audit Committee, as applicable. To date, we have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, that have materially affected us, including our operations, business strategy, results of operations, or financial condition.
Company Information
Name | Benitec Biopharma Inc. |
CIK | 0001808898 |
SIC Description | Pharmaceutical Preparations |
Ticker | BNTC - Nasdaq |
Website | |
Category | Non-accelerated filer Smaller reporting company |
Fiscal Year End | December 30 |